ArticleDigestive diseases and sciences2026
MELD and the Risk of Mortality Between Black and White Patients with Advanced Fibrosis.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeMELD has been well established as the gold standard metric for predicting mortality in patients with cirrhosis. Here, we hypothesized that Black race is an important factor in predicting mortality in patients with cirrhosis when controlling for social determinants of health.
methodsAll adults who had a liver biopsy showing F4 fibrosis at our institution from January 1, 2013 through July 1, 2021 were identified. Histology, fibrosis stage, and complete clinical data were abstracted. Patients were propensity matched based on age, gender, Charlson Comorbidity Index, and the CDC/ATSDR Social Vulnerability Index Themes 1, 2, and 4. Cox Proportional Hazard Modeling was used to identify if race was a predictor of 5-year liver-related mortality. Logistic regression analysis was performed comparing race, MELD 3.0, and their interaction on ninety-day liver-related mortality.
resultsOf 3572 patients having a liver biopsy, 64 Black and 61 White patients had F4 fibrosis after propensity matching. No significant differences between these groups existed for MELD scores. Liver-related mortality at 5 years was not significantly different between White and Black patients. Logistic regression analysis did not reveal an association between race and liver-related mortality.
conclusionBlack and White patients with similar comorbidities and social vulnerabilities had comparable liver-related mortality at similar MELD 3.0 scores. The data suggest that the MELD 3.0 score is equally predictive of mortality in Black and White patients.
Indexed as
Identifiers
42501222What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.